Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2020 Aug;104(8 Suppl 2):S1-S12.
doi: 10.1097/TP.0000000000003270.

Monitoring of Donor-specific Anti-HLA Antibodies and Management of Immunosuppression in Kidney Transplant Recipients: An Evidence-based Expert Paper

Marta Crespo  1 , Sofía Zárraga  2 , Ángel Alonso  3 , Isabel Beneyto  4 , Carmen Díaz Corte  5 , Ana M Fernandez Rodriguez  6 , Antonio Franco  7 , Domingo Hernández  8 , Francisco Manuel González-Roncero  9 , Carlos Jiménez Martín  10 , Luisa Jimeno  11 , Luis-Ricardo Lauzurica Valdemoros  12 , Santiago Llorente  11 , Auxiliadora Mazuecos  13 , Antonio Osuna  14 , Javier Paúl Ramos  15 , Alberto Rodríguez Benot  16 , Juan Carlos Ruiz San Millán  17 , Ana Sánchez Fructuoso  18 , Josep-Vicent Torregrosa  19 , Lluis Guirado  20 ; GREAT Study Group and Spanish Network for Research in Renal Diseases (REDINREN, RED16/0009)
Affiliations
Practice Guideline

Monitoring of Donor-specific Anti-HLA Antibodies and Management of Immunosuppression in Kidney Transplant Recipients: An Evidence-based Expert Paper

Marta Crespo et al. Transplantation. 2020 Aug.
No abstract available

PubMed Disclaimer

References

    1. Whalen HR, Glen JA, Harkins V, et al. High intrapatient tacrolimus variability is associated with worse outcomes in renal transplantation using a low-dose tacrolimus immunosuppressive regime. Transplantation. 2017; 101:430–436. doi:10.1097/TP.0000000000001129 - DOI
    1. Rodrigo E, Segundo DS, Fernández-Fresnedo G, et al. Within-patient variability in tacrolimus blood levels predicts kidney graft loss and donor-specific antibody development. Transplantation. 2016; 100:2479–2485. doi:10.1097/TP.0000000000001040 - DOI
    1. Gandhi MJ, Carrick DM, Jenkins S, et al. Lot-to-lot variability in HLA antibody screening using a multiplexed bead-based assay. Transfusion. 2013; 53:1940–1947. doi:10.1111/trf.12064 - DOI
    1. Pérez Sáez MJ, Alonso Melgar A, Cofan Pujol F, et al. Monitorización inmunológica postrasplante renal: ¿tiene impacto clínico? Nefrologia. 2016; 7:38–50
    1. Tambur AR, Campbell P, Claas FH, et al. Sensitization in transplantation: assessment of risk (STAR) 2017 working group meeting report. Am J Transplant. 2018; 18:1604–1614. doi:10.1111/ajt.14752 - DOI

Publication types

MeSH terms